Brief: Egetis Q1 Loss Widens To SEK 28.8 Mln

Egetis Therapeutics AB (publ)

26/04/2022 07:05

April 26 (Reuters) - Egetis Therapeutics AB (publ)
 EGTX.ST :
    * Q1 QUARTERLY NET REVENUE MSEK 7.1 (3.8)
    * Q1 QUARTERLY LOSS MSEK -28.8 (-19.3)

Source text for Eikon:  ID:nMFN1gRrjL 
Further company coverage:  EGTX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))